Atlas Trials

Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection

Clinical trial NCT00881517 · COMPLETED

Trial details

NCT number
NCT00881517
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Cytomegalovirus Infection
Start date
2009-06-01
Primary completion
2011-10-01
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.